Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30014263
Basic Information
VIS ID
TVIS30014263
Fusion event
HIV-PRDM2 integration
Validated
Yes
Detection method
invPCR
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2007
PubMed ID
17262715
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr1
Cytoband
p36.21
Reference genome
GRCh37/hg19
Start
14050073/13723578 (Hg38)
End
14050073/13723578 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA1A
Target gene
PRDM2
miRNAs that regulate target gene
hsa-mir-106b-3p
;
hsa-mir-541-5p
;
hsa-mir-7154-5p
;
hsa-mir-203b-3p
;
hsa-mir-6854-5p
;
hsa-mir-488-3p
;
hsa-mir-5195-3p
;
hsa-mir-145-5p
;
hsa-mir-8065
;
hsa-mir-3656
;
hsa-mir-6730-5p
;
hsa-mir-5681a
;
hsa-mir-708-5p
;
hsa-mir-3139
;
hsa-mir-28-5p
;
hsa-mir-4668-5p
;
hsa-mir-211-5p
;
hsa-mir-204-5p
;
hsa-mir-542-3p
;
hsa-mir-4504
;
hsa-mir-6866-3p
;
hsa-mir-188-5p
;
hsa-mir-605-5p
;
hsa-mir-4668-3p
;
hsa-mir-548c-3p
Nearest miRNA
hsa-mir-12136/Upstream/1144555; hsa-mir-101-1/Downstream/3135371;
Nearest TSS
ENST00000473358/Upstream/18723;
ENST00000502724/Downstream/7440;
Nearest CpG islands
None/Target,
chr1-CpG: 111/Upstream/22873
,
chr1-CpG: 116/Downstream/25194
Nearest cancer related gene
PRDM2
(TSG, No orient, 0)
Upstream sequence
AACTGGAGAAAGGAATTGGACGTGACAGATTTTGAAGGATCAGCAGCAGGGTTTGGCTCTGTTGACCACCCTCACTTCCTGGAGTCTTCCCCAGCTTTGG
Downstream sequence
TGATGCCATGTGCTTGGTGCCTCTTTGGCTCTGCGATGACTTCTAGGACTGGGACTCATTTGCTGTGCTTCTTCTTCCGTTTCATTCTTTGATAAGGGCA
Reference
Ikeda, T., et al. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis,2007, 195(5): 716-725.
Sample Information
×
Sample type
PBMC
Gender
Female
CpG Island Information
×
Download
Curate